Print the value of index0
  • Report:  #177165

Complaint Review: Avacore And Scalp Med

Avacore And Scalp Med Avacore, Scalpmed hair growth ripoffs Internet

  • Reported By:
    saint paul Minnesota
  • Submitted:
    Mon, February 20, 2006
  • Updated:
    Thu, April 03, 2014

I have been seeing new infomercials for a hairgrowth product called Scalpmed. A topical liquid placed on the scalp. This product is similar to Avacore which has been on the market for a longer period of time. Both of these products charge about 175.00 for a 60 day supply. The ripoff here is that both are simply renamed Minoxadil or Rogaine. This hair growth product has been available over the counter for years and costs about 30.00/ for a month supply. Rogaine works for some people but I have heard it grows hair that looks like peach fuzz not the complete thick hair that the informercials show. Just wanted to warn you.

Alan
saint paul, Minnesota
U.S.A.

2 Updates & Rebuttals


Company Representative

Culver City,
California,

Alan, we are sorry that you were bothered by our infomercials.

#3UPDATE Employee

Thu, April 03, 2014

Dear Alan, we’re sorry that you were bothered by our infomercials and believe that we are somehow similar to Avacore.  We assure you, Scalpmed is a completely separate product and we are not affiliated with Avacore. In fact, only Scalpmed has 6 US patents for hair regrowth formulation.  See our hair regrowth studies at: slideshare.net/scalpmed/scalp-med-consumer-trial-scalp-med-25290784.


Mark

Los Angeles,
California,
U.S.A.

Scalp Med works

#3UPDATE Employee

Wed, March 29, 2006

New York, NY January 25, 2005 The Electronic Retailing Self-Regulation Program
(ERSP) announced that Scalp Med Hair Restoration for Men and Women (Scalp Med),
marketed by Modern Health Labs, Inc. (MHL), has provided a reasonable basis for
establishment, safety, and performance claims.

ERSP, the electronic direct-response industry's self-regulatory forum, is administered by the Council of Better Business Bureaus and supervised by the National Advertising Review Council
(NARC). ERSP reviewed core claims that include:


ERSP determined that MHL provided a reasonable basis for the following performance claims:

Your hair will grow back thicker and fuller.
[I]ncredibly effective for both men and women.
...liquid actually gets sucked in, increased blood flow...stays on
follicle.
Thicken your hair the first time you use it.

ERSP further determined that Food and Drug Administration approval of the Vitadil formulations to regrow hair provided a reasonable basis for the claims that hair will grow back thicker and fuller and that Scalp Med will prevent hair loss, reverse thinning hair and re-grow hair. ERSP also noted that the marketer agreed to discontinue the claim ...start seeing results in weeks not months in future advertising.

With respect to its comparative claims against hair transplants, ERSP determined that MHL properly supported the statement ...works faster than a hair transplant. ERSP further
concluded that the claim ...results that I would get having surgery without having to have the surgery, was not unreasonably communicated and would not be misinterpreted by consumers.

Respond to this Report!